Women’s Health Market to Touch USD 41.05 Billion at 3.2% CAGR by 2027; Growing Focus on Women’s Health Worldwide to Positively Impact the Market: Fortune Business Insights™

Pune, India, Dec. 21, 2020 (GLOBE NEWSWIRE) — The global women’s health market size is projected to reach USD 41.05 billion by 2027, exhibiting a CAGR of 3.2% during the forecast period. The COVID-19 pandemic is likely to reemphasize the importance of woman health and boost the market, observes Fortune Business Insights™ in its report. The infection caused by the coronavirus, which has affected more men than women across the globe, has brought the issue of health of women in the spotlight. A UN policy brief released in April 2020 stated that women hold less secure jobs and earn lower wages, which makes them highly vulnerable to the adverse effects of this pandemic. More importantly, as the pandemic intensifies, women’s health will inevitably suffer.Industry Developments:September 2020: Health & Her, specialists in female wellness based in Cardiff, introduced an app to help women navigate their menopausal journey, which includes exercise suggestions, period tracking, and symptom assessment. The company also launched a novel supplement range called ‘Health & Her Perimenopause and Menopause Food Supplements’.September 2020: Evofem Biosciences announced the commercial release of Phexxi, its non-hormonal prescription vaginal gel, in the US. The product is designed to prevent pregnancy in reproductive-age women and can be used as an on-demand contraceptive.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/women-s-health-market-101847
Increasing Prevalence of Women-centric Diseases to Aid GrowthA leading factor aiding the women’s health market growth is the rising incidence of women-specific diseases and disorders around the globe. For example, the 2018 GLOBOCAN report by the International Agency for Research on Cancer (IARC) revealed that female breast cancer diagnoses stood at 2.1 million in 2018, accounting for approximately 11.6% of the total global cancer burden.Further, female breast cancer was the fifth leading cause of death, contributing to 6.6% of the total global deaths in 2018. Another prime example is osteoporosis in women, a disease that generally afflicts menopausal women, causing reduction in bone density. The National Osteoporosis Foundation, for example, estimates that 20% of Caucasian women aged 50 and above have osteoporosis.
Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/women-s-health-market-101847
As a result of their complex internal body dynamics, management of women’s health, especially post-pregnancy and post-menopause, when hormone imbalances are known to occur, requires high level of efficiency and accuracy. Products designed to facilitate effective management of women-centric diseases will, thus, play a crucial in augmenting this market in the forthcoming years.Robust Spending on Women’s Healthcare to Stoke Market Growth in North AmericaNorth America is expected to emerge as a major revenue generator for this market during the forecast period, having registered a market size of USD 18.00 billion in 2019. The primary reason for the region’s dominance in the market share is the large amount of funds allocated to enhance women’s healthcare across the US and Canada. This is a result of the spreading awareness about health issues and the growing prevalence of women-specific diseases in the region.Improving healthcare infrastructure, especially in Eastern European countries, is anticipated to bolster Europe’s position as the second-largest region in this market. Asia Pacific is expected to grow at the highest CAGR on account of the rising awareness about the importance women health.
Quick Buy –  women-s-health-market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101847
Launch of Digital Health Solutions for Women to Fuel InnovationSome of the leading players in this market that specialize in female wellness and health are coming out with path-breaking digital solutions to address the unique health issues faced by women. These solutions are aimed at enabling women to take care of their independently without affecting their daily routines.
List of Key Companies Profiled in this Market Report:Agile Therapeutics (New Jersey, USA)LUPIN (Mumbai, India)Merck & Co., Inc. (New Jersey, United States)Amgen Inc. (California, United States)Bayer AG (Leverkusen, Germany)AstraZeneca (Cambridge, UK)Eli Lilly and Company (Indiana, United States)Novartis AG (Basel, Switzerland)Pfizer Inc. (New York, United States)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/women-s-health-market-101847
Table of Contents:IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Women Related Disorders, By Key Countries/RegionNew Product LaunchesKey Mergers, Acquisition, and PartnershipsKey Industry TrendsImpact of COVID-19 on Women’s Health MarketGlobal Women’s Health Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By ApplicationContraceptivesOsteoporosisMenopauseInfertilityOthersMarket Analysis, Insights and Forecast – By Distribution ChannelHospital PharmaciesRetail PharmaciesOnline PharmaciesMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa